Botanical species · safety record

Cymbopogon jwarancusa

The EFSA Compendium of Botanicals holds 9 constituent measurements for Cymbopogon jwarancusa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cymbopogon jwarancusa subsp. olivieri (Boiss.) Soenarko

9Constituent measurements

0Safety records

8Cited sources

0Licensed products (Canada)

Also recorded as

Cymbopogon laniger (Desf.) Duthie

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
P-menth-1-en-3-one	Leaves	—	≤ 83 Percent	Gaschromatography (GC)	Resolve DOI
P-menth-1-en-3-one	Leaves	—	≥ 44.9 Percent	Gaschromatography (GC)	Resolve DOI
P-menth-1-en-3-one	Aerial part of plants	Essential oil	—	Gaschromatography (GC)	Resolve DOI
Alkaloids	Shoot	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Carvone	Leaves	Drying (dehydration)	1.19 Percent	GC-FID	No resolvable identifier
P-menth-1-en-3-one	Unspecified	—	—	Gaschromatography (GC)	No resolvable identifier
P-menth-1-en-3-one	Unspecified	Essential oil	—	—	No resolvable identifier
P-menth-1-en-3-one	Unspecified	Essential oil	—	—	No resolvable identifier
P-menth-1-en-3-one	Leaves	Essential oil	—	Gaschromatography (GC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Verma, V., Sobti, S. N., Atal, C. K. Chemical composition and inheritance pattern of five Cymbopogon species. Indian Perfumer, 1987, p. 295-305.
Singh, R.S., Pathak, M.G. Variability in herb yield and volatile constituents of Cymbopogon jwarancusa (Jones) Schult. cultivars. Industrial crops and products, 1994, vol. 2, no. 3, p. 197-199. DOI
Shahi, A. K., Sen, D. N. Note on Cymbopogon jwarancusa (Jones) Schult.-source of piperitone in Thar desert. Current Agriculture, 1989, p. 99-101.
Liu, Chutsin., Zhang, Jixian., Yiao, Ruiru., Gan, Lixian. Chemical studies on the essential oils of Cymbopogon genus. Huaxue Xuebao, 1981, p. 241-247.
Kayani, Safdar Ali., Masood, Ayeesha., Achakzai, Abdul Kabir Khan., Anbreen, Shahila. Distribution of secondary metabolites in plants of Quetta-Balochistan. PAKISTAN JOURNAL OF BOTANY, 2007, vol. 39, no. 4, p. 1173-1179.
Shahi, Ashok Kumar., Tava, Aldo. Essential oil composition of three Cymbopogon species of Indian Thar desert. Journal of Essential Oil Research, 1993, vol. 5, no. 6, p. 639-643.
Dar, M.Y., Shah, W.A., Rather, M.A., Qurishi, Y., Hamid, A., Qurishi, M.A. Chemical composition, in vitro cytotoxic and antioxidant activities of the essential oil and major constituents of Cymbopogon jawarancusa (Kashmir). Food Chemistry, 2011, vol. 129, no. 4, p. 1606-1611. DOI
Dhar, R.S., Dhar, A.K. Ontogenetic Variation in the Essential Oil Concentration and Its Constituents in the Five Genotypes of Cymbopogon jwarancusa (Jones) Schultz. Journal of Essential Oil Research, 1997, vol. 9, no. 4, p. 433-439.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature